Vincristine and prednisone vs vincristine, l-asparaginase, and prednisone for second remission induction of acute lymphocytic leukemia in children-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vincristine and prednisone vs vincristine, l-asparaginase, and prednisone for second remission induction of acute lymphocytic leukemia in children

Published:1979 Issue:4 Volume:6 Page:317-323
ISSN:0098-1532
Container-title:Medical and Pediatric Oncology
language:en
Short-container-title:Med. Pediatr. Oncol.

Author:

Herson Jay,Starling Kenneth A.,Dyment Paul G.,Humphrey G. Bennett,Pullen Jeanette,Vats Tribhawan

Publisher

Wiley

Subject

Cancer Research,Oncology,Pediatrics, Perinatology and Child Health

Reference9 articles.

1. L-asparaginase therapy in children with advanced leukemiaThe Southwest cancer chemotherapy study group

2. Toxicity of L-asparaginase in children with advanced leukemia

3. : 259 L-asparaginase in advanced childhood leukemia: Comparative trial of drug schedules singly and in combination. AACR Proceedings, 1970.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polyethylene Glycol-conjugated L-asparaginase Versus Native L-asparaginase in Combination With Standard Agents for Children With Acute Lymphoblastic Leukemia in Second Bone Marrow Relapse;Journal of Pediatric Hematology/Oncology;2011-12

2. An open-label, multicenter study of polyethylene glycol-L-asparaginase for the treatment of acute lymphoblastic leukemia;Cancer;1995-03-01

3. A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse;Investigational New Drugs;1992-08

4. Pediatric Neoplastic Disorders;Applied Therapeutics;1992

5. Remission induction and continuation therapy in children with their first relapse of acute lymphoid leukemia. A pediatric oncology group study;Cancer;1991-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3